Debreceno vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 482,607 | 502,903 | 533,035 | 27,548 | 690,959 | 762,292 | 817,273 | 829,453 |
| Profit before tax | 3,289 | 6,297 | 1,287 | 113 | 4,328 | 14,014 | - | 14,098 |
| Net profit | 2,796 | 5,352 | 1,094 | 96 | 2,454 | 10,687 | 17,718 | 10,532 |
| Equity | 87,068 | 90,000 | 87,121 | 546,414 | 547,867 | 556,430 | 568,566 | 579,095 |
| Liabilities | 22,532 | 33,045 | 37,497 | 36,206 | 35,648 | 34,680 | 26,543 | 37,433 |
| Non-current assets | 56,672 | 55,236 | 53,799 | 511,404 | 502,039 | 508,884 | 506,376 | 492,218 |
| Current assets | 52,769 | 67,658 | 70,764 | 71,160 | 81,420 | 82,107 | 88,646 | 124,213 |
| Total assets | 109,441 | 122,894 | 124,563 | 582,564 | 583,459 | 590,991 | 595,022 | 616,431 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 55,971 | 58,529 | 63,931 |
| Social insurance contributions | - | - | - | - | - | 57,788 | 61,392 | 64,572 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +94.6% | +4.2% | +6.0% | -94.8% | +2408.2% | +10.3% | +7.2% | +1.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.6% | 4.4% | 0.9% | 0.0% | 0.4% | 1.8% | 3.0% | 1.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 3.2% | 5.9% | 1.3% | 0.0% | 0.4% | 1.9% | 3.1% | 1.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.6% | 1.1% | 0.2% | 0.3% | 0.4% | 1.4% | 2.2% | 1.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.7% | 1.3% | 0.2% | 0.4% | 0.6% | 1.8% | - | 1.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.4 | 0.4 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 43,218 | 35,922 | 38,074 | 1,968 | 50,558 | 53,183 | 58,377 | 61,822 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Debreceno vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-26 | 0.02 |
| 2025-12-16 | 2025-12-30 | 0.03 |
| 2025-11-18 | 2025-11-25 | 0.01 |
| 2025-10-23 | 2025-10-30 | 26.25 |
| 2025-07-16 | 2025-07-28 | 6946.83 |
| 2025-02-10 | 2025-02-10 | 13.32 |
| 2025-01-26 | 2025-01-29 | 13.32 |
| 2025-01-16 | 2025-01-22 | 13.32 |
| 2024-10-24 | 2024-11-03 | 18.42 |
| 2024-09-17 | 2024-09-29 | 1.81 |
| 2024-07-25 | 2024-07-29 | 3466.10 |
| 2024-07-16 | 2024-07-24 | 4617.10 |
| 2024-02-19 | 2024-02-26 | 1.31 |
| 2024-01-23 | 2024-02-04 | 1.33 |
| 2024-01-16 | 2024-01-22 | 0.02 |
| 2023-12-18 | 2023-12-28 | 312.49 |
| 2023-03-16 | 2023-03-22 | 5281.40 |
| 2023-02-17 | 2023-02-26 | 462.51 |
| 2023-01-23 | 2023-01-31 | 0.17 |
| 2022-11-21 | 2022-11-23 | 61.72 |
| 2022-11-17 | 2022-11-18 | 61.72 |
| 2022-10-28 | 2022-10-30 | 0.17 |
| 2022-09-16 | 2022-09-28 | 46.27 |
Debreceno vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-11 | 2026-02-21 | 0.24 |
| 2026-01-29 | 2026-02-10 | 0.18 |
| 2026-01-27 | 2026-01-28 | 0.54 |
| 2026-01-24 | 2026-01-26 | 691.64 |
| 2026-01-23 | 2026-01-23 | 689.48 |
| 2024-09-29 | 2024-10-16 | 0.19 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Debreceno vaistine, UAB (company code 140786882) is a Private Limited Liability Company operating in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €829.5K, which was 1.5% higher year on year and 8.8% above the 2023 level, showing a steady upward sales trend over the last three years. Net profit for 2025 amounted to €10.5K, with a profit margin of 1.3%, after €17.7K in 2024 and €10.7K in 2023. The 2024 result was the strongest of the period, while 2025 profitability moderated despite higher revenue. At year-end 2025, total assets stood at €616.4K, equity at €579.1K and liabilities at €37.4K, indicating a very strong equity position and low leverage. The equity ratio was 93.9% and debt-to-equity 0.06. Asset turnover reached 1.35x, ROE was 1.8% and ROA 1.7%. Revenue per employee was €63.8K and profit per employee €810.